Group 1 - The European Commission has agreed to set a 15% cap on drug tariffs for American pharmaceuticals, providing protection for European companies [1] - President Trump announced a 100% tariff on all imported brand-name or patented drugs starting October 1, undermining the previously established EU-US drug tariff agreement [1] - Major European pharmaceutical companies like Roche, Novartis, and AstraZeneca have announced expansion projects in the US, which may allow them to avoid the new tariffs [1] Group 2 - The Belgian Pharmaceutical Association expressed that the industry expects a response from the EU regarding Trump's tax announcement, highlighting that it violates the EU-US agreement [2] - The uncertainty created by the tariff announcement is putting pressure on investment decisions across Europe [2]
特朗普单方面宣布药品高额关税 欧美贸易协议再陷混乱
Yang Shi Xin Wen·2025-09-26 10:31